Question

A patient with chronic liver disease presents with abdominal distention and jaundice. Upper GI endoscopy reveals non-bleeding varices. What is the drug of choice for primary prophylaxis?

• A. Propranolol
• B. Octreotide
• C. Midodrine
• D. Terlipressin

Hint:

Variceal Bleeding Management Summary:
Primary Prophylaxis (preventing the first bleed): Non-selective beta-blockers (Propranolol/Nadolol) OR Endoscopic Variceal Ligation (EVL).
Acute Bleeding Management: IV Octreotide/Terlipressin + Urgent EVL + IV Antibiotics (Ceftriaxone).

Answer 1

The Correct Option is A

Concept:
A patient with established, decompensated chronic liver disease undergoes a screening upper gastrointestinal endoscopy, which reveals the presence of significant esophageal varices that have not yet bled.
The clinical priority is to initiate primary prophylaxis—a pharmacological strategy designed specifically to reduce the high portal pressures and prevent the catastrophic, often fatal, first episode of variceal hemorrhage.
Explanation:
• In the setting of cirrhosis, severe portal hypertension forces blood to bypass the highly resistant, fibrotic liver via collateral portosystemic vessels. The most clinically dangerous of these collaterals are the esophageal varices.

• Once medium to large varices are identified on screening endoscopy, the immediate goal is to lower the portal venous pressure gradient (HVPG) below the critical threshold (usually $< 12$ mmHg) to prevent them from rupturing.

• The absolute pharmacological cornerstone and universally accepted "drug of choice" for the primary prophylaxis of esophageal variceal bleeding is the use of Non-Selective Beta-Blockers (NSBBs), such as Propranolol (Option A), Nadolol, or Carvedilol.

• Propranolol works via a highly effective dual mechanism: First, it blocks Beta-1 receptors in the heart, safely reducing heart rate and cardiac output. Second, and more importantly, it blocks Beta-2 receptors located in the splanchnic (mesenteric) vasculature.

• Blocking these Beta-2 receptors leaves the alpha-adrenergic receptors unopposed, causing profound splanchnic vasoconstriction. This dramatically reduces the total volume of arterial blood flowing into the portal venous system, thereby directly and significantly lowering the portal pressure and the tension on the variceal walls.

• Octreotide (Option B) and Terlipressin (Option D) are powerful intravenous splanchnic vasoconstrictors. However, they are used exclusively for the acute medical management of an active, ongoing variceal bleed; they are never used for long-term oral primary prophylaxis.

• Midodrine (Option C) is a systemic alpha-1 agonist used to increase systemic blood pressure in conditions like hepatorenal syndrome or severe dysautonomia, and it has no role in preventing variceal bleeding.
Final Answer:
Propranolol, a non-selective beta-blocker, is the standard pharmacological drug of choice for the primary prophylaxis of non-bleeding esophageal varices.